<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/dataseer-ml/../grobid-home/schemas/xsd/Grobid.xsd">
  <teiHeader xml:lang="en">
    <encodingDesc>
      <appInfo>
        <application ident="GROBID" version="0.5.6-SNAPSHOT" when="2019-07-08T06:19+0000">
          <ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
        </application>
      </appInfo>
    </encodingDesc>
    <fileDesc>
      <titleStmt>
        <title level="a" type="main">Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis</title>
      </titleStmt>
      <publicationStmt>
        <publisher/>
        <availability status="unknown">
          <licence/>
        </availability>
      </publicationStmt>
      <sourceDesc>
        <biblStruct>
          <analytic>
            <author>
              <persName>
                <forename type="first">Hamideh</forename>
                <surname>Aghaei</surname>
              </persName>
              <affiliation key="aff0">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
              <affiliation key="aff1">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
              <affiliation key="aff2">
                <orgName key="dep1" type="department">Department of Immunology</orgName>
                <orgName key="dep2" type="department">School of Medicine</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
            </author>
            <author>
              <persName>
                <forename type="first">Shayan</forename>
                <surname>Mostafaei</surname>
              </persName>
              <affiliation key="aff3">
                <orgName key="dep1" type="department">Department of Community Medicine</orgName>
                <orgName key="dep2" type="department">Faculty of Medicine</orgName>
                <orgName type="institution">Kermanshah University of Medical Sciences</orgName>
                <address>
                  <settlement>Kermanshah</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
            </author>
            <author>
              <persName>
                <forename type="first">Saeed</forename>
                <surname>Aslani</surname>
              </persName>
              <affiliation key="aff0">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
              <affiliation key="aff1">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
            </author>
            <author>
              <persName>
                <forename type="first">Ahmadreza</forename>
                <surname>Jamshidi</surname>
              </persName>
              <affiliation key="aff0">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
              <affiliation key="aff1">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
            </author>
            <author role="corresp">
              <persName>
                <forename type="first">Mahdi</forename>
                <surname>Mahmoudi</surname>
              </persName>
              <email>mahmoudim@tums.ac.ir</email>
              <affiliation key="aff0">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
              <affiliation key="aff1">
                <orgName type="department">Rheumatology Research Center</orgName>
                <orgName type="institution">Tehran University of Medical Sciences</orgName>
                <address>
                  <postBox>PO Box: 1411713137</postBox>
                  <settlement>Tehran</settlement>
                  <country key="IR">Iran</country>
                </address>
              </affiliation>
            </author>
            <author>
              <persName>
                <forename type="first">Hamideh</forename>
                <surname>Aghaei</surname>
              </persName>
            </author>
            <title level="a" type="main">Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis</title>
          </analytic>
          <monogr>
            <imprint>
              <date/>
            </imprint>
          </monogr>
          <idno type="DOI">10.1186/s12881-019-0754-6</idno>
          <note>R E S E A R C H A R T I C L E Open Access Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis * Correspondence: Full list of author information is available at the end of the article</note>
        </biblStruct>
      </sourceDesc>
    </fileDesc>
    <profileDesc>
      <textClass>
        <keywords>
          <term>Arthritis</term>
          <term>Meta-analysis</term>
          <term>Gene polymorphism</term>
          <term>killer cell immunoglobulin-like receptor</term>
          <term>Disease association</term>
        </keywords>
      </textClass>
      <abstract>
        <div>
          <head>Abstract</head>
          <p>
            <s>Background: Currently published studies investigating association between the killer cell immunoglobulin-like receptor (KIR) gene polymorphisms and rheumatoid arthritis (RA) reported inconsistent and contradictory results.</s>
            <s>Hence, we aim to carry out this comprehensive meta-analysis of all eligible studies meeting the inclusion criteria to achieve precise and comprehensive relationships between genetic variations in KIR gene cluster and risk of RA.</s>
            <s>Methods: Databases of Medline/PubMed and Scopus were searched to investigate case-control studies prior to May 2018.</s>
            <s>The associations between KIR gene polymorphisms and RA susceptibility were analyzed by computing the odds ratio (OR) and 95% confidence interval (95% CI) for each study.</s>
            <s>Results: A total of 11 comparative case-control studies involving 1847 RA patients and 2409 healthy individuals were included in this meta-analysis.</s>
            <s>Four significant associations of 2DL3 (OR = 0.591, 95% CI = 0.351-0.994;</s>
            <s>P = 0.047), 2DL5 (OR = 0.716, 95% CI = 0.601-0.853;</s>
            <s>P &lt; 0.001), 2DS5 (OR = 0.623, 95% CI = 0.393-0.988;</s>
            <s>P = 0.045), and 3DL3 (OR = 0.324, 95% CI = 0.129-0.814;</s>
            <s>P = 0.016) genes with decreased RA risk were discovered in this meta-analysis.</s>
            <s>Although, other KIR receptors including 2DL1, 2DL2, 2DL4, 3DL1, 3DL2, 3DS1, 2DS1-2DS4, and two pseudo gens of 2DP1 and 3DP1 displayed no significant association with predisposition to RA. Conclusions: These findings provide reliable evidence that 2DL3, 2DL5, 3DL3, and 2DS5 might have a potential protective role for RA.</s>
          </p>
        </div>
      </abstract>
    </profileDesc>
  </teiHeader>
  <text xml:lang="en">
    <body>
      <div>
        <head>Background</head>
        <p>
          <s>Rheumatoid arthritis (RA) is a common chronic autoinflammatory disorder, which is characterized by erosive articular lesions and progressive joint destruction, resulting in irreversible bone deformity and movement disabilities <ref target="#b0" type="bibr">[1,</ref>
            <ref target="#b1" type="bibr">2]</ref> .</s>
          <s>The overall prevalence of RA ranges from 0.5 to 1% in global populations <ref target="#b2" type="bibr">[3]</ref> .</s>
          <s>It predominantly affects women with a female to male ratio of 2:1.</s>
          <s>It is believed that the combination of genetic and environmental factors as well as epigenomic contributing factors can break the self-tolerance and provoke immune system against itself during autoimmunity <ref target="#b3" type="bibr">[4]</ref>
            <ref target="#b4" type="bibr">[5]</ref>
            <ref target="#b5" type="bibr">[6]</ref>
            <ref target="#b6" type="bibr">[7]</ref>
            <ref target="#b7" type="bibr">[8]</ref> .</s>
          <s>Current studies have reported approximately 60% genetic contribution in susceptibility to RA in various ethnic populations <ref target="#b8" type="bibr">[9]</ref>
            <ref target="#b9" type="bibr">[10]</ref>
            <ref target="#b10" type="bibr">[11]</ref> .</s>
          <s>Human leukocyte antigen (HLA)-DR, one of the histocompatibility genes in HLA class II region, is responsible for about 30% of genetic susceptibility to RA <ref target="#b11" type="bibr">[12]</ref> .</s>
          <s>Thus, several genes outside the HLA region are also pivotal for initiation and development of RA.</s>
          <s>As shown in previous studies, a number of genes, including PTPN22, PADI4, STAT4, TRAF1, TNFAIP3, CD40, and KIR have been associated with RA and drawn much attention to investigate more genetic elements contributing to RA risk <ref target="#b8" type="bibr">[9,</ref>
            <ref target="#b12" type="bibr">[13]</ref>
            <ref target="#b13" type="bibr">[14]</ref>
            <ref target="#b14" type="bibr">[15]</ref>
            <ref target="#b15" type="bibr">[16]</ref>
            <ref target="#b16" type="bibr">[17]</ref> .</s>
        </p>
        <p>
          <s>The essential role of natural killer (NK) cells in RA pathogenesis have been widely investigated in many studies.</s>
          <s>These cells are present in synovial fluid as well as the blood of RA patients and participate in inflammation and, therefore, damage of joints <ref target="#b17" type="bibr">[18,</ref>
            <ref target="#b18" type="bibr">19]</ref> .</s>
          <s>In normal physiological conditions, NK cells are able to eliminate target cells with little or no expression of HLA class I molecules on them.</s>
          <s>Beside cytotoxic function, their ability to secrete cytokines underlines the role of NK cells in development of autoimmune settings <ref target="#b19" type="bibr">[20]</ref> .</s>
          <s>The efficient functional activity of NK cells is governed by three distinct receptor families including, C-type lectin-like group, immunoglobulin (Ig)-like superfamily, and natural cytotoxicity receptors (NCR) <ref target="#b20" type="bibr">[21]</ref> .</s>
          <s>The KIRs (CD 158 family) are expressed mainly on NK cells and a few proportions of T lymphocytes.</s>
          <s>HLA class I molecules are considered to be the major ligands for KIRs <ref target="#b21" type="bibr">[22]</ref> .</s>
          <s>The cluster of KIR genes is mapped on the leukocyte receptor complex (LRC) locus on chromosome 19q13.4</s>
          <s>which is extremely polymorphic among individuals and codes for glycoprotein receptors acting in inhibitory and activating manner <ref target="#b22" type="bibr">[23]</ref> .</s>
          <s>In humans, 17 highly homologous genes have been recognized for KIR genes encoding receptors containing 9 inhibitory, 6 activating, and 2 pseudogenes <ref target="#b23" type="bibr">[24,</ref>
            <ref target="#b24" type="bibr">25]</ref> .</s>
          <s>KIR receptors are categorized based on the number of their extracellular Ig-like domains (2D or 3D) and whether they have short (S) or long (L) cytoplasmic tail.</s>
          <s>Two pseudogenes (2DP1 and 3DP1) do not encode functional receptors <ref target="#b25" type="bibr">[26]</ref> .</s>
          <s>Inhibitory KIRs contain long intracellular tails and transduce signals through immunoreceptor tyrosinebased inhibitory motifs (ITIM).</s>
          <s>On the other hand, activating signals are generated through stimulation of a transmembrane adaptor molecule, namely DNAX activation protein of 12 kDa (DAP12), which possess domains for immunoreceptor tyrosine-based activating motifs (ITAM) <ref target="#b26" type="bibr">[27,</ref>
            <ref target="#b27" type="bibr">28]</ref> .</s>
        </p>
        <p>
          <s>The association of KIR gene polymorphisms has already been demonstrated in several autoimmune disorders <ref target="#b28" type="bibr">[29,</ref>
            <ref target="#b29" type="bibr">30]</ref> .</s>
          <s>Previously, 11 genetic studies have tried to clarify the role of KIR polymorphisms in susceptibility to RA.</s>
          <s>Nonetheless, findings from these studies seem to be contradictory in some cases.</s>
          <s>This discrepancy may be due to small sample sizes, insufficient statistical power and ethnic variations among different populations.</s>
          <s>Meta-analysis is a statistical method that combines data from multiple researches to establish a reliable estimation.</s>
          <s>Therefore, in this meta-analysis, we intend to provide a comprehensive evaluation of previously published studies about KIR association with RA susceptibility to have a conclusive and consistent understanding of the role of these molecules in RA pathogenesis.</s>
        </p>
      </div>
      <div>
        <head>Methods</head>
      </div>
      <div>
        <head>Literature search strategy</head>
        <p>
          <s>In the current meta-analysis, a systematic literature search was performed to identify relevant published articles in which associations between KIR variations and RA susceptibility were examined (up to May 2018).</s>
          <s>The electronic databases including Medline/PubMed and Scopus were searched using the following search keywords and subject terms: "The killer cell immunoglobulin-like receptors" or "KIR" or "KIRs", "rheumatoid arthritis," or "RA" and "polymorphism" or "variation" or "single nucleotide polymorphism" or "SNP".</s>
          <s>All searched studies were retrieved, and their references were also reviewed to discover additional pertinent studies.</s>
          <s>Original data collected in English language and human population studies.</s>
        </p>
      </div>
      <div>
        <head>Inclusion and exclusion criteria</head>
        <p>
          <s>A study would be included if met following statements: a) independent case-control studies which assess the association of the KIR polymorphisms and the risk of RA; b) sufficient data for calculating the odds ratios (ORs) and 95% confidence intervals (CIs); c) studies with adequate data representing the genotype and allele frequency of patient and healthy subjects.</s>
          <s>Accordingly, the exclusion criteria were the following: a) reported duplicate publications and overlapping data b) studies without any information of detailed polymorphism frequencies c) Case reports, letter, review, comment, or abstract that published in journals ( <ref target="#tab_0" type="table">Table 1</ref> , <ref target="#fig_0" type="figure">Fig. 1</ref> ).</s>
        </p>
      </div>
      <div subtype="dataseer">
        <head>Data extraction and quality assessment</head>
        <p>
          <s id="dataset-1" type="Tabular data">The following items were recorded from all 11 eligible studies: first author's name, publication year, country of origin, ethnicity of the study population, genotyping method, total number of cases and controls, and frequencies of KIR gene polymorphisms.</s>
          <s>The results were compared and discrepancies were resolved by consensus.</s>
          <s>For evaluating the quality of the involved studies the Newcastle-Ottawa Scale (NOS) was used <ref target="#b30" type="bibr">[31]</ref> .</s>
          <s>Total NOS scores ranged from 0 to 9. We regarded a study scored 0-3, 4-6, or 7-9 as a low, moderate, or high-quality study, respectively.</s>
        </p>
      </div>
      <div>
        <head>Statistical analysis</head>
        <p>
          <s>The effect size of association between KIR gene polymorphisms and RA susceptibility was determined by odds ratios (ORs) and their 95% confidence intervals (CI) comparing experimental cases to controls for each study.</s>
          <s>The phenotypic frequency (pf %) of each KIRs was assessed as the percentage of positive numbers between all samples.</s>
          <s>Genotypic frequency (gf %) among all samples was computed by means of the formula gf = 1-(1 -pf ) 1/2 .</s>
          <s>In the current meta-analysis, heterogeneity among studies was measured by Cochran's Q-statistic (P value&lt; 0.10 was considered statistically significant heterogeneity) and quantified by I-squared (I 2 ) tests <ref target="#b30" type="bibr">[31]</ref> .</s>
          <s>I 2 values of 25, 50 and 75% were described as low, moderate, and high heterogeneity, respectively.</s>
          <s>A P value&gt; 0.10 or I 2 value&lt; 50% demonstrate that the pooled OR was calculated using the fixed-effect model; otherwise, a random-effect model was used.</s>
          <s>Moreover, we implemented funnel plots to survey the existence of potential publication bias.</s>
          <s>Egger's linear regression test and Begg's test were employed to estimate the funnel plot asymmetry, and P &lt; 0.05 was considered to be representative of statistically significant <ref target="#b31" type="bibr">[32]</ref> .</s>
          <s>If heterogeneity presented among studies, sensitivity analysis would be carried out.</s>
          <s>All statistical analyses were achieved by utilizing STATA (version 14.0; Stata Corporation, College Station, TX) and MedCalc version 13.</s>
        </p>
      </div>
      <div>
        <head>Results</head>
      </div>
      <div>
        <head>Characteristics of eligible studies</head>
        <p>
          <s>Regarding to aforementioned inclusion and exclusion criteria, a total of 11 case-control studies reporting the association between KIR gene and RA were available for this meta-analysis.</s>
          <s>(Shown in <ref target="#fig_0" type="figure">Fig. 1</ref> ) The 11 published studies contained 1847 RA patients and 2409 healthy controls in various ethnic populations including four European, four Asian and three American countries <ref target="#b11" type="bibr">[12,</ref>
            <ref target="#b32" type="bibr">[33]</ref>
            <ref target="#b33" type="bibr">[34]</ref>
            <ref target="#b34" type="bibr">[35]</ref>
            <ref target="#b35" type="bibr">[36]</ref>
            <ref target="#b36" type="bibr">[37]</ref>
            <ref target="#b37" type="bibr">[38]</ref>
            <ref target="#b38" type="bibr">[39]</ref>
            <ref target="#b39" type="bibr">[40]</ref>
            <ref target="#b40" type="bibr">[41]</ref> .</s>
          <s>All the recruited papers were published from 2001 to 2016.</s>
          <s>According to the NOS criteria, all eligible studies had a total score ranging from 7 to 9. A detailed characteristic of the genotype and allele frequencies of various studies involved in this meta-analysis are provided in <ref target="#tab_2" type="table">Table 2</ref> .</s>
        </p>
      </div>
      <div>
        <head>Main results</head>
        <p>
          <s>A summary of meta-analysis findings concerning associations between KIR variations and RA is represented in <ref target="#tab_2" type="table">Table 2</ref> .</s>
          <s>Meta-analysis indicated four markedly significant negative associations of 2DL3 (OR = 0.591, 95% CI = 0.351-0.994;</s>
          <s>P = 0.047), 2DL5 (OR = 0.716, 95% CI = 0.601-0.853;</s>
          <s>P &lt; 0.001), 2DS5 (OR = 0.623, 95% CI = 0.393-0.988;</s>
          <s>P = 0.045), and 3DL3 (OR = 0.324, 95% CI = 0.129-0.814;</s>
          <s>P = 0.016) with RA susceptibility <ref target="#fig_1" type="figure">(Fig. 2)</ref> .</s>
          <s>Nevertheless, other KIR genes, including 2DL1, 2DL2, 2DL4, 3DL1, 3DL2, 3DS1, 2DS1-2DS4, and two pseudo gens of 2DP1 and 3DP1 showed no significant correlation with predisposition to RA.</s>
        </p>
      </div>
      <div>
        <head>Sensitivity analysis</head>
        <p>
          <s>A sensitivity analysis was performed by sequential omission of individual and groups of studies.</s>
          <s>The pooled ORs did not deviate with sequential omission of any participants or group of studies, indicating that our results were statistically robust <ref target="#fig_2" type="figure">(Fig. 3</ref> ).</s>
        </p>
      </div>
      <div>
        <head>Heterogeneity and publication bias</head>
        <p>
          <s>In our meta-analysis, significant inter-study heterogeneity (I 2 &gt; 50%; P &lt; 0.10) was found in 2DL1 (I 2 = 73.8%;</s>
          <s>P &lt; 0.001), 2DL2 (I 2 = 80.2%; P &lt; 0.001), 2DL3 (I 2 = 71.1%;</s>
          <s>P &lt; 0.001), 2DS1 (I 2 = 50.7%;</s>
          <s>P = 0.047), 2DS2 (I 2 = 59.9%;</s>
          <s>P = 0.01), 2DS5 (I 2 = 86.7%;</s>
          <s>P &lt; 0.001), 3DL1 (I 2 = 68.1%;</s>
          <s>P &lt; 0.001), 3DS1 (I 2 = 68.4%;</s>
          <s>P = 0.002), and 2DP1 (I 2 = 78.7%;</s>
          <s>P = 0.002).</s>
          <s>Therefore, the random-effects model was used to assess the relationship.</s>
          <s>On the contrary, other KIR polymorphisms revealed no significant heterogeneity and fixed-effects model were utilized to pool the result.</s>
          <s>Egger's linear regression test and Begg's test were applied to check publication bias.</s>
          <s>Funnel plots also did not show any apparent asymmetry <ref target="#fig_1" type="figure">(Fig. 4, Table 2</ref> ).</s>
          <s>No publication bias was established for KIR genes in overall analysis (Egger's regression test P &gt; 0.1).</s>
        </p>
      </div>
      <div>
        <head>Discussion</head>
        <p>
          <s>We intend to perform this meta-analysis to achieve a comprehensive analysis of the previously published studies about KIR association with RA susceptibility to figure out a conclusive and consistent understanding of the RA pathogenesis underlying KIR gene polymorphisms.</s>
          <s>The analysis revealed significant association of 2DL3, 2DL5, 2DS5, and 3DL3 genes, which decreased RA risk.</s>
          <s>RA is a common autoimmune disorder, which mainly affects the joints and brings about bone erosions.</s>
          <s>One subject of debate at present is the role of genetic elements, which are involved in the initiation and development of RA.</s>
          <s>Integration analysis of genome wide association study (GWAS) successfully reported newly natural killer cell mediated cytotoxicity pathway as a contributing genes which are associated with RA <ref target="#b41" type="bibr">[42]</ref> .</s>
        </p>
        <p>
          <s>Human NK cells are CD3 bright subsets are highly involved in cytokine secretion especially interferon (IFN)-γ.</s>
          <s>According to previous researches, following diminished frequency of NK cells in peripheral blood, CD56 bright subsets could migrate through blood vessels to inflamed joints and propagated in the synovial fluid of RA patients <ref target="#b42" type="bibr">[43,</ref>
            <ref target="#b43" type="bibr">44]</ref> .</s>
          <s>Enhancement of NK cells in synovial fluids resulted in high amount of IFN-γ production which, in turn, contributed to perpetuation of inflammatory milieu in this autoimmune disorder <ref target="#b44" type="bibr">[45]</ref> .</s>
          <s>Of note, IFN-γ per se has ability to activate surrounding macrophages through cell-cell contact to release more inflammatory mediators, mostly tumor necrosis factor (TNF)-α which reinforce inflammatory environment in arthritic joints <ref target="#b45" type="bibr">[46]</ref> .</s>
          <s>NK cells are also responsible for killing target cells that are not able to express self-MHC molecules <ref target="#b46" type="bibr">[47]</ref> .</s>
          <s>Their function is highly modulated by several activating and inhibitory membrane receptors, particularly KIRs <ref target="#b25" type="bibr">[26]</ref> .</s>
          <s>In 2001, the first case-control research regarding association of KIRs and RA undertaken by <ref type="bibr">Yen et al. that</ref> showed the KIR2DS2 involvement in the development of rheumatoid vasculitis <ref target="#b32" type="bibr">[33]</ref> .</s>
          <s>From 2001 up to now, several studies were carried out to delineate the relationship of KIR genes repertoire with susceptibility to RA in diverse ethnic populations, though the findings appear inconsistent and conflicting.</s>
          <s>Thus, we decided to fulfill this comprehensive meta-analysis by incorporating data of 11 relevant studies in order to reevaluate the interest associations.</s>
          <s>The overall results divulged that KIR2DL3, KIR2DL5, KIR3DL3, and KIR2DS5 were negatively associated with susceptibility to RA, providing evidence that KIRs might potentially affect RA progression.</s>
          <s>On the other hand, other KIR genes, including 2DL1, 2DL2, 2DL4, 3DL1, 3DL2, 3DS1, 2DS1-2DS4, and two pseudo gens of 2DP1 and 3DP1 displayed no significant association with RA risk in our study.</s>
        </p>
        <p>
          <s>KIR genes consist of two haplotypes; The "A" haplotype contains inhibitory genes and one activating gene (KIR2DS4) with protective effect against autoimmunities.</s>
          <s>"B" haplotype, on the other hand, exhibits more activating gens (KIR2DS1, -2DS2, -2DS3, -2DS4, -2DS5, and -3DS1) and inhibitory genes, KIR2DL2 and KIR2DL5 that increase the risk of autoimmune disorders <ref target="#b23" type="bibr">[24,</ref>
            <ref target="#b25" type="bibr">26,</ref>
            <ref target="#b47" type="bibr">48]</ref> .</s>
          <s>It is widely accepted that the proper activation of NK cells depends on the equilibrium of activating and inhibitory KIR receptors.</s>
          <s>Considering their high degree of polymorphisms in two levels of gene content and allelic variations, they are mostly related to many autoimmune diseases, such as RA, ankylosing spondylitis, psoriasis vulgaris, scleroderma, SLE, diabetes mellitus, Crohn's disease, Behçet's disease, and etc. <ref target="#b20" type="bibr">[21,</ref>
            <ref target="#b38" type="bibr">39,</ref>
            <ref target="#b48" type="bibr">[49]</ref>
            <ref target="#b49" type="bibr">[50]</ref>
            <ref target="#b50" type="bibr">[51]</ref>
            <ref target="#b51" type="bibr">[52]</ref>
            <ref target="#b52" type="bibr">[53]</ref>
            <ref target="#b53" type="bibr">[54]</ref> .</s>
        </p>
        <p>
          <s>In this study, KIR2DL3 showed negative association with the RA risk and in agreement with the results of Parkash et al. and Ramirez-De los Santos et al. studies, it provided protection against RA <ref target="#b11" type="bibr">[12,</ref>
            <ref target="#b37" type="bibr">38]</ref> .</s>
          <s>In this context, it has been clarified earlier that KIR2DL3 inhibits the production of cytokines like IFN-γ.</s>
          <s>Of note, NK cells-derived IFN-γ is a fundamental source for Th1 priming in RA <ref target="#b54" type="bibr">[55]</ref> .</s>
          <s>Therefore, lack of IFN-γ secretion by NK cells could reduce T cells autoreactivity <ref target="#b55" type="bibr">[56]</ref> .</s>
        </p>
        <p>
          <s>In addition, our results also suggest that KIR2DL5 and KIR2DS5 were protective against RA.</s>
          <s>KIR2DL5 and KIR2DS5 both are present at haplotype B, but they function differently in the inhibitory and activating manner, respectively.</s>
          <s>Meanwhile, their respective ligands have not been discovered successfully <ref target="#b56" type="bibr">[57]</ref> .</s>
        </p>
        <p>
          <s>Interestingly, KIR2DS5 display protective effect in some diseases, despite an activating function.</s>
          <s>A study by <ref type="bibr">Nowak et al.</ref> showed that KIR2DS5 plays a protective role in ankylosing spondylitis, endometriosis, and acute kidney graft rejection with no significant effect in RA.</s>
          <s>According to their literature, this paradoxical protective effect is likely related to the pronounced role of KIR2DS5 in tolerance induction and, therefore, prevention of autoimmune conditions <ref target="#b36" type="bibr">[37]</ref> .</s>
          <s>It should be noted that this phenomenon might be due to linkage disequilibrium (LD) with some neighboring inhibitory loci in KIR haplotype.</s>
          <s>Thus, LD can contribute to modulate gene expression and give explanation as a putative cause of protective effect of KIR2DS5.</s>
        </p>
        <p>
          <s>It has been reported previously that KIR2DL5 significantly had protective effect in SLE patients.</s>
          <s>Due to inhibitory signals from KIR2DL5, NK cells functions can be suppressed in the onset of SLE.</s>
          <s>Moreover, the less prevalence of KIR2DL5 associated with the increased predisposition to overall infections in SLE patients <ref target="#b57" type="bibr">[58]</ref> .</s>
          <s>Although their findings could not support the relation of KIR2DL5 in RA individuals, we observed a highly significant association of KIR2DL5 with risk of RA in our population study, which may impress the disease susceptibility in the same manner as does in SLE.</s>
        </p>
        <p>
          <s>KIR3DL3 is one of the so-called "framework" genes, which is present in all KIR haplotypes.</s>
          <s>It is located in the centromeric half of haplotype at 5'-end and its ligand is uncertain yet <ref target="#b58" type="bibr">[59]</ref> .</s>
          <s>This inhibitory receptor can prohibit NK cell cytotoxicity via single ITIM motif in its cytoplasmic tail.</s>
          <s>Unlike previous reports, we revealed that a negative association exist between KIR3DL3 and RA risk.</s>
          <s>, and 2DL3 as a protective factor for RA risk only in East Asians, but not in Caucasians <ref target="#b59" type="bibr">[60]</ref> .</s>
          <s>In the current study, we incorporated more studies with further ethnic populations to achieve better results.</s>
          <s>The only consistence results obtained from current meta-analysis and that of Li et al. study, was 2DL3 as protective factor in RA patients <ref target="#b59" type="bibr">[60]</ref> .</s>
          <s>While the previous meta-analysis found two positive associations of KIR genes with RA susceptibility, we found that all significantly associated KIR genes had negative association with RA risk.</s>
          <s>KIR2DL5, KIR2DS5, and KIR3DL3 conferred a protective role in RA development <ref target="#b59" type="bibr">[60]</ref> .</s>
        </p>
        <p>
          <s>This meta-analysis provides comprehensive information from 11 case-control studies to better understanding of KIR and RA association, but some shortcomings should be considered.</s>
          <s>First, between-study heterogeneity was observed which might distort analysis.</s>
          <s>Second, the number of published studies entered in this research was relatively small which restrict the estimation power of the present study.</s>
          <s>However, considering the increased number of subjects included in this meta-analysis, the obtained results are more reliable than the previous analysis <ref target="#b59" type="bibr">[60]</ref> .</s>
          <s>Additionally, various populations of Europe, Asia, and American nations were included in the current meta-analysis, increasing the general conclusion of the results to populations worldwide.</s>
        </p>
      </div>
      <div>
        <head>Conclusion</head>
        <p>
          <s>In consideration of all, present meta-analysis identified that KIR2DL3, KIR2DL5, KIR2DS5, and KIR3DL3 seem to have a potential protective role in RA risk.</s>
          <s>However, premised on forenamed limitations, further research studies are still required to explore the association between the KIR polymorphisms and RA risk with a larger sample sizes and controls in order to validate these findings.</s>
        </p>
      </div>
      <figure xml:id="fig_0">
        <head>Fig. 1</head>
        <label>1</label>
        <figDesc>Fig. 1 Flow chart of specifications and procedure for the literature search and study selection</figDesc>
      </figure>
      <figure xml:id="fig_1">
        <head>Fig. 2</head>
        <label>2</label>
        <figDesc>Fig. 2 Forest plot. The plot shows results of pooled OR for (a) 2DL3, (b) 2DL5, (c) 2DS5, and (d) 3DL3 genes</figDesc>
      </figure>
      <figure xml:id="fig_2">
        <head>Fig. 3</head>
        <label>3</label>
        <figDesc>Fig. 3 Influence plot. The graph presents sensitivity analysis for (a) 2DL3, (b) 2DL5, (c) 2DS5, and (d) 3DL3 genes</figDesc>
      </figure>
      <figure xml:id="fig_3">
        <head>Fig. 4</head>
        <label>4</label>
        <figDesc>Fig. 4 Funnel plot. The plot displays publication bias and heterogeneity of the results between studies for (a) 2DL3, (b) 2DL5, (c) 2DS5, and (d) 3DL3 genes</figDesc>
      </figure>
      <figure type="table" validated="false" xml:id="tab_0">
        <head>Table 1</head>
        <label>1</label>
        <figDesc>Characteristics of the included studies in meta-analysisPCR Polymerase Chain Reaction, PCR-SSP Polymerase Chain Reaction-Sequence Specific Primer, PCR-SSOP Polymerase Chain Reaction-Sequence Specific Oligonucleotide Probes</figDesc>
        <table>Author (Ref) 
Published Year Country/Race 
Detection Technique RA Patients Controls KIR Polymorphisms 

Yen [33] 
2001 
Western European/ 
Caucasian 

PCR 
70 
76 
2DS1, 2DS2 

Yen [34] 
2006 
Taiwanese/Asians 
PCR-SSP 
122 
96 
2DL1-3, 2DS1-4, 3DL1-2, 3DS1 

Majorczyk [35] 
2007 
Poland/Caucasian PCR-SSP 
177 
243 
2DL1-3, 2DS1-5, 2DS4full*001, 
2DS4Del*(003,005,006), 3DL1, 3DS1 

Middleton [36] 
2007 
Northern Ireland/ 
Caucasian 

PCR-SSOP 
331 
354 
2DL1-5, 2DS1-5, 3DL1-3, 3DS1 

Nowak [37] 
2010 
Poland/Caucasian PCR 
366 
690 
2DS5 

Yasutaka Kimoto [58] 
2010 
Japanese 
PCR-SSP 
72 
256 
2DL1-5, 2DS1-5, 3DL1-3, 3DS1 

Ram'ırez-De los Santos [12] 2012 
Western Mexico 
PCR-SSP 
100 
100 
2DL1-5, 2DS1-5, 3DL1-3, 3DS1, 
2DP1, 3DP1 

Prakash [38] 
2014 
North Indian 
PCR-SSP 
100 
100 
2DL1-5, 2DS1-5, 3DL1-3, 3DS1, 
2DP1 

Masoumeh Nazari [39] 
2015 
Iran/Caucasian 
PCR-SSP 
400 
372 
2DL1-5, 2DL5A,B, 2DS1-3, 2DS4-001, 
2DS4-003, 2DS5 
3DL1-3, 3DS1, 2DP1, 3DP1-001, 
3DP1-004 

Nishimura [40] 
2015 
Brazil 
PCR-SSP 
40 
40 
2DL3, 2DL5, 3DL1 

Velarde-de la Cruz [41] 
2016 
Western Mexico 
PCR-SSP 
69 
82 
2DL1-5, 3DL1-3, 2DS1-5, 3DS1, 
2DP1, 3DP1 

</table>
      </figure>
      <figure type="table" validated="true" xml:id="tab_2">
        <head>Table 2</head>
        <label>2</label>
        <figDesc>Meta-analysis of the pooled association between KIR polymorphisms and RA disease</figDesc>
        <table>Polymorphism 
No. of studies 

RA case n/N 

Control n/N 

P-value 
Pooled OR (95% C.I) 

Heterogeneity Test (Q, 

I 

2 

; 

P -value) 

Publication Bias (Begg's Test, 
P-value; Egger's test, 

P-value) 

Effect Model 

2DL1 

8 

1277/1371 

1323/1395 

0.736 
0.865 (0.372-2.012) 

(29.12, 73.8%; 
P-value &lt; 0.001) 
(Begg's Test, 0.53; Egger's test, 0.51) 

Random 

2DL2 

8 

712/1371 

748/1439 

0.747 
1.063 (0.735-1.536) 

(35.34, 80.2%; 
P-value &lt; 0.001) 
(Begg's Test, 0.38; Egger's test, 0.28) 

Random 

2DL3 

9 

1224/1411 

1295/1435 

0.047 
0.591 (0.351-0.994) 

(27.65, 71.1%; 
P-value &lt; 0.001) 
(Begg's Test, 0.99; Egger's test, 0.24) 

Random 

2DL4 

6 

1075/1082 

1059/1066 

0.864 
1.097 (0.382-3.152) 

(0.15, 0.0%; 
P-value = 0.99) 
(Begg's Test, 0.09; Egger's test, 0.001) 

Fixed 

2DL5 

7 

614/1112 

686/1096 

&lt; 0.001 
0.716 (0.601-0.853) 

(8.3, 27.6%; 
P-value = 0.217) 
(Begg's Test, 0.99; Egger's test, 0.59) 

Fixed 

2DS1 

8 

623/1372 

651/1389 

0.560 
0.932 (0.736-1.118) 

(14.22, 50.7%; 
P-value = 0.047) 
(Begg's Test, 0.17; Egger's test, 0.22) 

Random 

2DS2 

9 

703/1441 

734/1518 

0.617 
1.068 (0.826-1.380) 

(19.98, 59.9%; 

P-value = 0.01) 
(Begg's Test, 0.35; Egger's test, 0.25) 

Random 

2DS3 

8 

372/1371 

411/1395 

0.176 
0.891 (0.735-1.053) 

(6.49, 0.0%; 
P-value = 0.483) 
(Begg's Test, 0.90; Egger's test, 0.60) 

Fixed 

2DS4 

9 

1153/1550 

1094/1528 

0.170 
1.150 (0.942-1.404) 

(12.57, 36.3%; 
P-value = 0.127) 
(Begg's Test, 0.25; Egger's test, 0.28) 

Fixed 

2DS5 

8 

386/1615 

664/1989 

0.045 
0.623 (0.393-0.988) 

(52.67, 86.7%; 
P-value &lt; 0.001) 
(Begg's Test, 0.53; Egger's test, 0.71) 

Random 

3DL1 

9 

1296/1411 

1338/1435 

0.710 
0.894 (0.494-1.616) 

(25.07, 68.1%; 
P-value &lt; 0.001) 
(Begg's Test, 0.25; Egger's test, 0.067) 

Random 

3DL2 

7 

1182/1204 

1149/1160 

0.157 
0.585 (0.278-1.230) 

(1.37, 0.0%; 
P-value = 0.967) 
(Begg's Test, 0.37; Egger's test, 0.001) 

Fixed 

3DL3 

6 

1067/1086 

1060/1066 

0.016 
0.324 (0.129-0.814) 

(4.28, 0.0%; 
P-value = 0.508) 
(Begg's Test, 0.19; Egger's test, 0.001) 

Fixed 

3DS1 

8 

511/1371 

564/1395 

0.569 
0.917 (0.681-1.235) 

(22.14, 68.4%; 
P-value = 0.002) 
(Begg's Test, 0.99; Egger's test, 0.48) 

Random 

2DP1 

4 

633/669 

625/654 

0.924 
0.930 (0.206-4.185) 

(14.1, 78.7%; 
P-value = 0.002) 
(Begg's Test, 0.73; Egger's test, 0.85) 

Random 

3DP1 

3 

603/606 

575/578 

0.976 
1.025 (0.206-5.107) 

(0.001, 0.0%; 
P-value = 0.99) 
(Begg's Test, NA; Egger's test, NA) 

Fixed 

NA Not applicable, Values in bold indicate statistically significant differences </table>
      </figure>
    </body>
    <back>
      <div type="acknowledgement">
        <div>
          <head>Acknowledgements</head>
          <p>
            <s>Not applicable.</s>
          </p>
        </div>
        <div>
          <head>Funding</head>
          <p>
            <s>This work was supported by Deputy of Research, Tehran University of Medical Sciences (Grant No. 97-03-41-40378).</s>
            <s>The funders were not involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</s>
          </p>
        </div>
        <div>
          <head>Availability of data and materials</head>
          <p>
            <s>All data generated or analyzed during this study are included in this published article.</s>
          </p>
        </div>
      </div>
      <div type="annex">
        <div>
          <p>
            <s>Authors' contributions HA performed literature search and prepared the draft of the paper.</s>
            <s>SHM performed statistical analysis and read the manuscript critically and designed the Tables.</s>
            <s>SA assessed the obtained information, participated in manuscript preparation, and read the manuscript.</s>
            <s>AJ designed the work, edited and read the manuscript critically.</s>
            <s>MM developed the main idea, designed the work, and read the manuscript critically.</s>
            <s>All authors have read and approved the manuscript.</s>
          </p>
          <p>
            <s>Ethics approval and consent to participate Not applicable.</s>
          </p>
        </div>
        <div>
          <head>Consent for publication</head>
          <p>
            <s>Not applicable.</s>
          </p>
        </div>
        <div>
          <head>Competing interests</head>
          <p>
            <s>The authors declare that they have no competing interests.</s>
          </p>
        </div>
      </div>
      <div type="references">
        <listBibl>
          <biblStruct xml:id="b0">
            <analytic>
              <title level="a" type="main">Cytokines in the pathogenesis of rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">I</forename>
                  <forename type="middle">B</forename>
                  <surname>Mcinnes</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Schett</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Nat Rev Immunol</title>
              <imprint>
                <biblScope unit="volume">7</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="429" to="471" unit="page"/>
                <date type="published" when="2007"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b1">
            <analytic>
              <title level="a" type="main">New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Fadaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Arjijord</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Int J Rheum Dis</title>
              <imprint>
                <biblScope unit="volume">20</biblScope>
                <biblScope unit="issue">3</biblScope>
                <biblScope from="287" to="97" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b2">
            <analytic>
              <title level="a" type="main">Systematic literature review and meta-analysis of tumor necrosis factor-alpha experienced rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">F</forename>
                  <surname>Wells</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">R</forename>
                  <surname>Curtis</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">A</forename>
                  <surname>Betts</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <surname>Douglas</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <forename type="middle">X</forename>
                  <surname>Du</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Ganguli</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clin Ther</title>
              <imprint>
                <biblScope unit="volume">39</biblScope>
                <biblScope unit="issue">8</biblScope>
                <biblScope from="1680" to="1694" unit="page"/>
                <date type="published" when="1682"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b3">
            <analytic>
              <title level="a" type="main">Epigenetic modifications and therapy in multiple sclerosis</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Jafari</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">R</forename>
                  <surname>Javan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Karami</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Ahmadi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Jafarnejad</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Neuromolecular Med</title>
              <imprint>
                <biblScope unit="volume">19</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="11" to="23" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b4">
            <analytic>
              <title level="a" type="main">Immunity: Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Karami</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Amirzargar</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Gharshasbi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mjg</forename>
                  <surname>Nicknam</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Genes Immun</title>
              <imprint>
                <biblScope unit="volume">18</biblScope>
                <biblScope unit="issue">3</biblScope>
                <biblScope unit="page">170</biblScope>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b5">
            <analytic>
              <title level="a" type="main">Pharmacotherapy: Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Ahmadi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Gharibi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Dolati</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Rostamzadeh</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Baradaran</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Younesi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mjb</forename>
                  <surname>Yousefi</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Biomed Pharmacother</title>
              <imprint>
                <biblScope unit="volume">87</biblScope>
                <biblScope from="596" to="608" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b6">
            <analytic>
              <title level="a" type="main">Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">M</forename>
                  <surname>Foma</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Karami</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mjir</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Inflamm Res</title>
              <imprint>
                <biblScope unit="volume">66</biblScope>
                <biblScope unit="issue">12</biblScope>
                <biblScope from="1057" to="73" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b7">
            <analytic>
              <title level="a" type="main">IRF 7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Rezaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Gharibdoost</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Kavosi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Dashti</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Imeni</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Mostafaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mji</forename>
                  <surname>Vodjgani</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Int J Rheum Dis</title>
              <imprint>
                <biblScope unit="volume">20</biblScope>
                <biblScope unit="issue">10</biblScope>
                <biblScope from="1551" to="61" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b8">
            <analytic>
              <title level="a" type="main">Update on the genetic architecture of rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <surname>Kim</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">Y</forename>
                  <surname>Bang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">S</forename>
                  <surname>Lee</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">C</forename>
                  <surname>Bae</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Nat Rev Rheumatol</title>
              <imprint>
                <biblScope unit="volume">13</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="13" to="24" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b9">
            <analytic>
              <title level="a" type="main">Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">J</forename>
                  <surname>Mousavi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Chopra</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Akhlaghi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mjj</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Cell Physiol</title>
              <imprint>
                <biblScope unit="volume">234</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="335" to="382" unit="page"/>
                <date type="published" when="2018"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b10">
            <analytic>
              <title level="a" type="main">Epigenetic alterations underlying autoimmune diseases</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Karami</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">R</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Malekshahi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mhja</forename>
                  <surname>Nicknam</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Autoimmunity</title>
              <imprint>
                <biblScope unit="volume">49</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="69" to="83" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b11">
            <analytic>
              <title level="a" type="main">Associations of killer cell immunoglobulin-like receptor genes with rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Ramirez-De Los Santos</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">E</forename>
                  <surname>Sanchez-Hernandez</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">F</forename>
                  <surname>Munoz-Valle</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">A</forename>
                  <surname>Palafoxsanchez</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">Y</forename>
                  <surname>Rosales-Rivera</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Garcia-Iglesias</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Daneri-Navarro</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">G</forename>
                  <surname>Ramirezduenas</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Dis Markers</title>
              <imprint>
                <biblScope unit="volume">33</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="201" to="207" unit="page"/>
                <date type="published" when="2012"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b12">
            <analytic>
              <title level="a" type="main">Genetic markers as therapeutic target in rheumatoid arthritis: a game changer in clinical therapy?</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">M</forename>
                  <surname>Ali</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Vino</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Rheumatol Int</title>
              <imprint>
                <biblScope unit="volume">36</biblScope>
                <biblScope unit="issue">11</biblScope>
                <biblScope from="1601" to="1608" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b13">
            <analytic>
              <title level="a" type="main">Immunogenetics of rheumatoid arthritis: understanding functional implications</title>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">C</forename>
                  <surname>Messemaker</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">W</forename>
                  <surname>Huizinga</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Kurreeman</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Autoimmun</title>
              <imprint>
                <biblScope unit="volume">64</biblScope>
                <biblScope from="74" to="81" unit="page"/>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b14">
            <monogr>
              <title/>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Abbasi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">J</forename>
                  <surname>Mousavi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Jamalzehi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Alimohammadi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">H</forename>
                  <surname>Bezvan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Mohammadi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Aslani</forename>
                  <surname>Sjjocp</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="2018"/>
              </imprint>
            </monogr>
            <note>strategies toward rheumatoid arthritis therapy; the old and the new</note>
          </biblStruct>
          <biblStruct xml:id="b15">
            <analytic>
              <title level="a" type="main">Pathology p: Lack of association between STAT4 single nucleotide polymorphisms and Iranian juvenile rheumatoid arthritis patients</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Salmaninejad</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Poursani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Ziaee</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Njf</forename>
                  <surname>Rezaei</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Fetal Pediatr Pathol</title>
              <imprint>
                <biblScope unit="volume">36</biblScope>
                <biblScope unit="issue">3</biblScope>
                <biblScope from="177" to="83" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b16">
            <monogr>
              <title level="m" type="main">Histone variants expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Asadipour</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">V</forename>
                  <surname>Hassan-Zadeh</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Aryaeian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Shahram</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mahmoudi</forename>
                  <surname>Mjijord</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b17">
            <analytic>
              <title level="a" type="main">Natural killer cells in human autoimmune disorders</title>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">A</forename>
                  <surname>Fogel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">M</forename>
                  <surname>Yokoyama</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">R</forename>
                  <surname>French</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Arthritis Res Ther</title>
              <imprint>
                <biblScope unit="volume">15</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope unit="page">216</biblScope>
                <date type="published" when="2013"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b18">
            <analytic>
              <title level="a" type="main">Natural killer cells and their role in rheumatoid arthritis: friend or foe?</title>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Shegarfi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Naddafi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Mirshafiey</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Sci World J</title>
              <imprint>
                <date type="published" when="2012"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b19">
            <analytic>
              <title level="a" type="main">Human diversity of killer cell immunoglobulin-like receptors and disease</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Rajalingam</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Korean J Hematology</title>
              <imprint>
                <biblScope unit="volume">46</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="216" to="244" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b20">
            <analytic>
              <title level="a" type="main">Killer immunoglobulin receptor genes in spondyloarthritis</title>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">W</forename>
                  <surname>Kuijpers</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Vendelbosch</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Berg</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">L</forename>
                  <surname>Baeten</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Curr Opin Rheumatol</title>
              <imprint>
                <biblScope unit="volume">28</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="368" to="75" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b21">
            <analytic>
              <title level="a" type="main">Autoimmune rheumatic diseases and their association with killer immunoglobulin-like receptor genes</title>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">H</forename>
                  <surname>Salim</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Jobim</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">F</forename>
                  <surname>Jobim</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">M</forename>
                  <surname>Xavier</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Rev Bras Reumatol</title>
              <imprint>
                <biblScope unit="volume">51</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="351" to="357" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b22">
            <analytic>
              <title level="a" type="main">The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism</title>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">C</forename>
                  <surname>Hsu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Chida</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">E</forename>
                  <surname>Geraghty</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Dupont</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Immunol Rev</title>
              <imprint>
                <biblScope unit="volume">190</biblScope>
                <biblScope from="40" to="52" unit="page"/>
                <date type="published" when="2002"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b23">
            <analytic>
              <title level="a" type="main">Killer-cell immunoglobulin-like receptor (KIR) nomenclature report</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">G</forename>
                  <surname>Marsh</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Parham</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Dupont</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">E</forename>
                  <surname>Geraghty</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Trowsdale</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Middleton</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Vilches</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Carrington</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Witt</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">A</forename>
                  <surname>Guethlein</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Tissue Antigens</title>
              <imprint>
                <biblScope unit="volume">62</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="79" to="86" unit="page"/>
                <date type="published" when="2002"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b24">
            <analytic>
              <title level="a" type="main">Distribution of KIR genes in the Iranian population</title>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Tajik</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Shahsavar</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Mousavi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">F</forename>
                  <surname>Radjabzadeh</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Tissue Antigens</title>
              <imprint>
                <biblScope unit="volume">74</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="22" to="31" unit="page"/>
                <date type="published" when="2009"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b25">
            <analytic>
              <title level="a" type="main">The extensive polymorphism of KIR genes</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Middleton</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Gonzelez</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Immunology</title>
              <imprint>
                <biblScope unit="volume">129</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="8" to="19" unit="page"/>
                <date type="published" when="2010"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b26">
            <analytic>
              <title level="a" type="main">Hanging in the balance. KIR and their role in disease</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">P</forename>
                  <surname>Williams</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">R</forename>
                  <surname>Bateman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">I</forename>
                  <surname>Khakoo</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Mol Interv</title>
              <imprint>
                <biblScope unit="volume">5</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="226" to="266" unit="page"/>
                <date type="published" when="2005"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b27">
            <analytic>
              <title level="a" type="main">DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">W</forename>
                  <surname>Mcvicar</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">S</forename>
                  <surname>Taylor</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Gosselin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Willette-Brown</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">I</forename>
                  <surname>Mikhael</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">L</forename>
                  <surname>Geahlen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">C</forename>
                  <surname>Nakamura</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Linnemeyer</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">E</forename>
                  <surname>Seaman</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">K</forename>
                  <surname>Anderson</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Biol Chem</title>
              <imprint>
                <biblScope unit="volume">273</biblScope>
                <biblScope unit="issue">49</biblScope>
                <biblScope from="32934" to="32976" unit="page"/>
                <date type="published" when="1998"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b28">
            <monogr>
              <title level="m" type="main">Association study between killer immunoglobulin-like receptor polymorphisms and ankylosing spondylitis disease: an updated meta-analysis</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Rezaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Mostafaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mahmoudi</forename>
                  <surname>Mjijord</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="2018"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b29">
            <monogr>
              <title level="m" type="main">The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Fathollahi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Aslani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Mostafaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Rezaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mjir</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <imprint>
                <biblScope unit="volume">2018</biblScope>
                <biblScope from="1" to="10" unit="page"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b30">
            <analytic>
              <title level="a" type="main">Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</title>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Stang</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Eur J Epidemiol</title>
              <imprint>
                <biblScope unit="volume">25</biblScope>
                <biblScope unit="issue">9</biblScope>
                <biblScope from="603" to="608" unit="page"/>
                <date type="published" when="2010"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b31">
            <analytic>
              <title level="a" type="main">Bias in meta-analysis detected by a simple, graphical test</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Egger</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Davey</forename>
                  <surname>Smith</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Schneider</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Minder</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clinical research ed)</title>
              <imprint>
                <biblScope unit="volume">315</biblScope>
                <biblScope unit="issue">7109</biblScope>
                <biblScope from="629" to="663" unit="page"/>
                <date type="published" when="1997"/>
              </imprint>
            </monogr>
            <note>BMJ</note>
          </biblStruct>
          <biblStruct xml:id="b32">
            <analytic>
              <title level="a" type="main">Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">H</forename>
                  <surname>Yen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <forename type="middle">E</forename>
                  <surname>Moore</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Nakajima</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Scholl</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">J</forename>
                  <surname>Schaid</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">M</forename>
                  <surname>Weyand</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">J</forename>
                  <surname>Goronzy</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Exp Med</title>
              <imprint>
                <biblScope unit="volume">193</biblScope>
                <biblScope unit="issue">10</biblScope>
                <biblScope from="1159" to="67" unit="page"/>
                <date type="published" when="2001"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b33">
            <analytic>
              <title level="a" type="main">Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">H</forename>
                  <surname>Yen</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">H</forename>
                  <surname>Lin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">C</forename>
                  <surname>Tsai</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">C</forename>
                  <surname>Wu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <forename type="middle">T</forename>
                  <surname>Ou</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">J</forename>
                  <surname>Hu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">W</forename>
                  <surname>Liu</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Scand J Rheumatol</title>
              <imprint>
                <biblScope unit="volume">35</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="124" to="131" unit="page"/>
                <date type="published" when="2006"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b34">
            <analytic>
              <title level="a" type="main">Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Majorczyk</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Pawlik</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <surname>Luszczek</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">I</forename>
                  <surname>Nowak</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Wisniewski</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Jasek</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Kusnierczyk</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Genes Immun</title>
              <imprint>
                <biblScope unit="volume">8</biblScope>
                <biblScope unit="issue">8</biblScope>
                <biblScope from="678" to="83" unit="page"/>
                <date type="published" when="2007"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b35">
            <analytic>
              <title level="a" type="main">No association in frequency of KIR receptors in patients with rheumatoid arthritis from Northern Ireland</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Middleton</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Meenagh</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">D</forename>
                  <surname>Wright</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Tissue Antigens</title>
              <imprint>
                <biblScope unit="volume">69</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="577" to="82" unit="page"/>
                <date type="published" when="2007"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b36">
            <analytic>
              <title level="a" type="main">Does the KIR2DS5 gene protect from some human diseases?</title>
              <author>
                <persName>
                  <forename type="first">I</forename>
                  <surname>Nowak</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Majorczyk</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Wisniewski</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Pawlik</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Magott-Procelewska</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Passowiczmuszynska</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Malejczyk</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Ploski</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Giebel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Barcz</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">PLoS One</title>
              <imprint>
                <biblScope unit="volume">5</biblScope>
                <biblScope unit="issue">8</biblScope>
                <biblScope unit="page">12381</biblScope>
                <date type="published" when="2010"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b37">
            <analytic>
              <title level="a" type="main">Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among north Indian population</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Prakash</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Alam</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">U</forename>
                  <surname>Bharadwaj</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Aggarwal</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">N</forename>
                  <surname>Mishra</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Agrawal</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Hum Immunol</title>
              <imprint>
                <biblScope unit="volume">75</biblScope>
                <biblScope unit="issue">8</biblScope>
                <biblScope from="802" to="809" unit="page"/>
                <date type="published" when="2014"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b38">
            <analytic>
              <title level="a" type="main">Association of Killer Cell Immunoglobulin-like Receptor Genes in Iranian patients with rheumatoid arthritis</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Nazari</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Rahmani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Akhlaghi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Beigy</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Azarian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Shamsian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Akhtari</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Mansouri</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">PLoS One</title>
              <imprint>
                <biblScope unit="volume">10</biblScope>
                <biblScope unit="issue">12</biblScope>
                <biblScope unit="page">143757</biblScope>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b39">
            <analytic>
              <title level="a" type="main">The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis</title>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">E</forename>
                  <surname>Nishimura</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Sachetto</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">T</forename>
                  <surname>Costallat</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">A</forename>
                  <surname>Yazbek</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">C</forename>
                  <surname>Londe</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <forename type="middle">G</forename>
                  <surname>Guariento</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">B</forename>
                  <surname>Marques</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">B</forename>
                  <surname>Bertolo</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clinics</title>
              <imprint>
                <biblScope unit="volume">70</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="408" to="420" unit="page"/>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b40">
            <analytic>
              <title level="a" type="main">KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients</title>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <forename type="middle">E</forename>
                  <surname>Velarde-De La Cruz</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <forename type="middle">E</forename>
                  <surname>Sanchez-Hernandez</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">F</forename>
                  <surname>Munoz-Valle</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <forename type="middle">A</forename>
                  <surname>Palafoxsanchez</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Ramirez-De Los Santos</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">O</forename>
                  <surname>Graciano-Machuca</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Garcia-Iglesias</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Montoya-Buelna</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">G</forename>
                  <surname>Ramirez-Duenas</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Immunopharmacol Immunotoxicol</title>
              <imprint>
                <biblScope unit="volume">38</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="303" to="312" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b41">
            <analytic>
              <title level="a" type="main">Subclinical synovitis assessed by ultrasound predicts flare and progressive bone erosion in rheumatoid arthritis patients with clinical remission: a systematic review and metaanalysis</title>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Han</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Geng</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <surname>Deng</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Zhang</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">J Rheumatol</title>
              <imprint>
                <biblScope unit="volume">43</biblScope>
                <biblScope unit="issue">11</biblScope>
                <biblScope from="2010" to="2018" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b42">
            <analytic>
              <title level="a" type="main">A subset of natural killer cells is greatly expanded within inflamed joints</title>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Dalbeth</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Mfc</forename>
                  <surname>Callan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Arthritis Rheumatism</title>
              <imprint>
                <biblScope unit="volume">46</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="1763" to="72" unit="page"/>
                <date type="published" when="2002"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b43">
            <analytic>
              <title level="a" type="main">Natural killer cells in the synovial fluid of rheumatoid arthritis patients exhibit a CD56bright,CD94bright,CD158negative phenotype</title>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Pridgeon</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <forename type="middle">P</forename>
                  <surname>Lennon</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Pazmany</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">N</forename>
                  <surname>Thompson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">E</forename>
                  <surname>Christmas</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">J</forename>
                  <surname>Moots</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Rheumatology</title>
              <imprint>
                <biblScope unit="volume">42</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="870" to="878" unit="page"/>
                <date type="published" when="2003"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b44">
            <analytic>
              <title level="a" type="main">NK cells in autoimmune diseases: linking innate and adaptive immune responses</title>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Gianchecchi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">V</forename>
                  <surname>Delfino</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Fierabracci</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Autoimmun Rev</title>
              <imprint>
                <biblScope unit="volume">17</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="142" to="54" unit="page"/>
                <date type="published" when="2018"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b45">
            <analytic>
              <title level="a" type="main">The role of natural killer cells in the pathogenesis of rheumatoid arthritis: major contributors or essential homeostatic modulators?</title>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">J</forename>
                  <surname>Ahern</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">M</forename>
                  <surname>Brennan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Immunol Lett</title>
              <imprint>
                <biblScope unit="volume">136</biblScope>
                <biblScope unit="issue">2</biblScope>
                <biblScope from="115" to="136" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b46">
            <monogr>
              <title level="m" type="main">Innate or adaptive immunity? The example of natural killer cells</title>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Vivier</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <forename type="middle">H</forename>
                  <surname>Raulet</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Moretta</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">A</forename>
                  <surname>Caligiuri</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Zitvogel</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <forename type="middle">L</forename>
                  <surname>Lanier</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">M</forename>
                  <surname>Yokoyama</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Ugolini</forename>
                  <surname>Sjs</surname>
                </persName>
              </author>
              <imprint>
                <date type="published" when="2011"/>
                <biblScope unit="volume">331</biblScope>
                <biblScope from="44" to="49" unit="page"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b47">
            <analytic>
              <title level="a" type="main">The yin and Yang of HLA and KIR in human disease</title>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Kulkarni</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">P</forename>
                  <surname>Martin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Carrington</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Semin Immunol</title>
              <imprint>
                <biblScope unit="volume">20</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="343" to="52" unit="page"/>
                <date type="published" when="2008"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b48">
            <analytic>
              <title level="a" type="main">Analysis of killer cell immunoglobulin-like receptor genes and their HLA ligands in Iranian patients with ankylosing spondylitis</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">R</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Karami</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Mohseni</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">A</forename>
                  <surname>Amirzargar</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">E</forename>
                  <surname>Farhadi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Ahmadzadeh</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">H</forename>
                  <surname>Nicknam</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Iran J Allergy Asthma Immunol</title>
              <imprint>
                <biblScope unit="volume">15</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="27" to="38" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b49">
            <analytic>
              <title level="a" type="main">Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris</title>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <surname>Łuszczek</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mańczak</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Cisło</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Nockowski</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Wiśniewski</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Jasek</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Kuśnierczyk</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Hum Immunol</title>
              <imprint>
                <biblScope unit="volume">65</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="758" to="66" unit="page"/>
                <date type="published" when="2004"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b50">
            <analytic>
              <title level="a" type="main">Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Fallahian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Sobhani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Ghoroghi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Poursani</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Dolati</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Hosseinpour</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <surname>Gharibdoost</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Clin Rheumatol</title>
              <imprint>
                <biblScope unit="volume">36</biblScope>
                <biblScope unit="issue">4</biblScope>
                <biblScope from="853" to="62" unit="page"/>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b51">
            <analytic>
              <title level="a" type="main">Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Akhtari</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Farazmand</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Mahmoudi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Akbarian</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Ahmadzadeh</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Z</forename>
                  <surname>Mirkazemi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Mostafaei</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">R</forename>
                  <surname>Jamshidi</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Lupus</title>
              <imprint>
                <biblScope unit="volume">25</biblScope>
                <biblScope unit="issue">11</biblScope>
                <biblScope from="1244" to="53" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b52">
            <analytic>
              <title level="a" type="main">Association between killer cell immunoglobulinlike receptor (KIR) polymorphisms and systemic lupus erythematosus (SLE) in populations: a PRISMA-compliant meta-analysis</title>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">L</forename>
                  <surname>Liang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <forename type="middle">J</forename>
                  <surname>Ma</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">Z</forename>
                  <surname>Tan</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Medicine</title>
              <imprint>
                <biblScope unit="volume">96</biblScope>
                <biblScope unit="issue">10</biblScope>
                <biblScope unit="page">6166</biblScope>
                <date type="published" when="2017"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b53">
            <analytic>
              <title level="a" type="main">Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease</title>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Diaz-Pena</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <forename type="middle">R</forename>
                  <surname>Vidal-Castineira</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Moro-Garcia</forename>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">A</forename>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Alonso-Arias</forename>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <surname>Castrosantos</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Hum Immunol</title>
              <imprint>
                <biblScope unit="volume">77</biblScope>
                <biblScope unit="issue">1</biblScope>
                <biblScope from="104" to="113" unit="page"/>
                <date type="published" when="2016"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b54">
            <analytic>
              <title level="a" type="main">Natural killer cells in human autoimmunity</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Flodstrom-Tullberg</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <forename type="middle">T</forename>
                  <surname>Bryceson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">F</forename>
                  <forename type="middle">D</forename>
                  <surname>Shi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">P</forename>
                  <surname>Hoglund</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <forename type="middle">G</forename>
                  <surname>Ljunggren</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Curr Opin Immunol</title>
              <imprint>
                <biblScope unit="volume">21</biblScope>
                <biblScope unit="issue">6</biblScope>
                <biblScope from="634" to="674" unit="page"/>
                <date type="published" when="2009"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b55">
            <analytic>
              <title level="a" type="main">NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion</title>
              <author>
                <persName>
                  <forename type="first">B</forename>
                  <surname>Morandi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Bougras</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">W</forename>
                  <forename type="middle">A</forename>
                  <surname>Muller</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Ferlazzo</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Munz</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Eur J Immunol</title>
              <imprint>
                <biblScope unit="volume">36</biblScope>
                <biblScope unit="issue">9</biblScope>
                <biblScope from="2394" to="400" unit="page"/>
                <date type="published" when="2006"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b56">
            <analytic>
              <title level="a" type="main">Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations</title>
              <author>
                <persName>
                  <forename type="first">K</forename>
                  <forename type="middle">S</forename>
                  <surname>Campbell</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <forename type="middle">K</forename>
                  <surname>Purdy</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Immunology</title>
              <imprint>
                <biblScope unit="volume">132</biblScope>
                <biblScope unit="issue">3</biblScope>
                <biblScope from="315" to="340" unit="page"/>
                <date type="published" when="2011"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b57">
            <analytic>
              <title level="a" type="main">Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections</title>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Kimoto</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">T</forename>
                  <surname>Horiuchi</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Tsukamoto</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">C</forename>
                  <surname>Kiyohara</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">H</forename>
                  <surname>Mitoma</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Uchino</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">I</forename>
                  <surname>Furugo</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Yoshizawa</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">A</forename>
                  <surname>Ueda</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">S</forename>
                  <surname>Harashima</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Rheumatology</title>
              <imprint>
                <biblScope unit="volume">49</biblScope>
                <biblScope unit="issue">7</biblScope>
                <biblScope from="1346" to="53" unit="page"/>
                <date type="published" when="2010"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b58">
            <analytic>
              <title level="a" type="main">KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families</title>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">P</forename>
                  <surname>Martin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">R</forename>
                  <forename type="middle">M</forename>
                  <surname>Single</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <forename type="middle">J</forename>
                  <surname>Wilson</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">J</forename>
                  <surname>Trowsdale</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">M</forename>
                  <surname>Carrington</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Immunogenetics</title>
              <imprint>
                <biblScope unit="volume">60</biblScope>
                <biblScope unit="issue">12</biblScope>
                <biblScope from="767" to="74" unit="page"/>
                <date type="published" when="2008"/>
              </imprint>
            </monogr>
          </biblStruct>
          <biblStruct xml:id="b59">
            <analytic>
              <title level="a" type="main">Association between KIR gene polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis</title>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <surname>Li</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Q</forename>
                  <surname>Xia</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">D</forename>
                  <surname>Fan</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">G</forename>
                  <surname>Cai</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">X</forename>
                  <surname>Yang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Wang</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Xin</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">N</forename>
                  <surname>Ding</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">Y</forename>
                  <surname>Hu</surname>
                </persName>
              </author>
              <author>
                <persName>
                  <forename type="first">L</forename>
                  <surname>Liu</surname>
                </persName>
              </author>
            </analytic>
            <monogr>
              <title level="j">Hum Immunol</title>
              <imprint>
                <biblScope unit="volume">76</biblScope>
                <biblScope unit="issue">8</biblScope>
                <biblScope from="565" to="70" unit="page"/>
                <date type="published" when="2015"/>
              </imprint>
            </monogr>
          </biblStruct>
        </listBibl>
      </div>
    </back>
  </text>
</TEI>
